Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics

Anthony Chau, Auinash Kalsotra

Research output: Contribution to journalReview article

Abstract

Myotonic Dystrophy type 1 (DM1), the most prevalent adult onset muscular dystrophy, is a trinucleotide repeat expansion disease caused by CTG expansion in the 3'-UTR of DMPK gene. This expansion results in the expression of toxic gain-of-function RNA that forms ribonuclear foci and disrupts normal activities of RNA-binding proteins belonging to the MBNL and CELF families. Changes in alternative splicing, translation, localization, and mRNA stability due to sequestration of MBNL proteins and up-regulation of CELF1 are key to DM1 pathology. However, recent discoveries indicate that pathogenic mechanisms of DM1 involves many other factors as well, including repeat associated translation, activation of PKC-dependent signaling pathway, aberrant polyadenylation, and microRNA deregulation. Expression of the toxic repeat RNA culminates in the developmental remodeling of the transcriptome, which produces fetal isoforms of proteins that are unable to fulfill the physiological requirements of adult tissues. This review will describe advances in the understanding of DM1 pathogenesis as well as current therapeutic developments for DM1.

Original languageEnglish (US)
Pages (from-to)377-390
Number of pages14
JournalDevelopmental Dynamics
Volume244
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Poisons
Trinucleotide Repeat Expansion
RNA
Fetal Proteins
Pathology
Myotonic Dystrophy
Polyadenylation
RNA-Binding Proteins
Muscular Dystrophies
RNA Stability
Alternative Splicing
3' Untranslated Regions
MicroRNAs
Transcriptome
Protein Isoforms
Up-Regulation
Therapeutics
Genes
Proteins

Keywords

  • Alternative splicing
  • Antisense oligonucleotides
  • Developmental reprogramming
  • Myotonic dystrophy
  • RNA toxicity

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Developmental insights into the pathology of and therapeutic strategies for DM1 : Back to the basics. / Chau, Anthony; Kalsotra, Auinash.

In: Developmental Dynamics, Vol. 244, No. 3, 01.03.2015, p. 377-390.

Research output: Contribution to journalReview article

@article{f486bf5da96f438a9e6d1d53e5710273,
title = "Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics",
abstract = "Myotonic Dystrophy type 1 (DM1), the most prevalent adult onset muscular dystrophy, is a trinucleotide repeat expansion disease caused by CTG expansion in the 3'-UTR of DMPK gene. This expansion results in the expression of toxic gain-of-function RNA that forms ribonuclear foci and disrupts normal activities of RNA-binding proteins belonging to the MBNL and CELF families. Changes in alternative splicing, translation, localization, and mRNA stability due to sequestration of MBNL proteins and up-regulation of CELF1 are key to DM1 pathology. However, recent discoveries indicate that pathogenic mechanisms of DM1 involves many other factors as well, including repeat associated translation, activation of PKC-dependent signaling pathway, aberrant polyadenylation, and microRNA deregulation. Expression of the toxic repeat RNA culminates in the developmental remodeling of the transcriptome, which produces fetal isoforms of proteins that are unable to fulfill the physiological requirements of adult tissues. This review will describe advances in the understanding of DM1 pathogenesis as well as current therapeutic developments for DM1.",
keywords = "Alternative splicing, Antisense oligonucleotides, Developmental reprogramming, Myotonic dystrophy, RNA toxicity",
author = "Anthony Chau and Auinash Kalsotra",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/dvdy.24240",
language = "English (US)",
volume = "244",
pages = "377--390",
journal = "Developmental Dynamics",
issn = "1058-8388",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Developmental insights into the pathology of and therapeutic strategies for DM1

T2 - Back to the basics

AU - Chau, Anthony

AU - Kalsotra, Auinash

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Myotonic Dystrophy type 1 (DM1), the most prevalent adult onset muscular dystrophy, is a trinucleotide repeat expansion disease caused by CTG expansion in the 3'-UTR of DMPK gene. This expansion results in the expression of toxic gain-of-function RNA that forms ribonuclear foci and disrupts normal activities of RNA-binding proteins belonging to the MBNL and CELF families. Changes in alternative splicing, translation, localization, and mRNA stability due to sequestration of MBNL proteins and up-regulation of CELF1 are key to DM1 pathology. However, recent discoveries indicate that pathogenic mechanisms of DM1 involves many other factors as well, including repeat associated translation, activation of PKC-dependent signaling pathway, aberrant polyadenylation, and microRNA deregulation. Expression of the toxic repeat RNA culminates in the developmental remodeling of the transcriptome, which produces fetal isoforms of proteins that are unable to fulfill the physiological requirements of adult tissues. This review will describe advances in the understanding of DM1 pathogenesis as well as current therapeutic developments for DM1.

AB - Myotonic Dystrophy type 1 (DM1), the most prevalent adult onset muscular dystrophy, is a trinucleotide repeat expansion disease caused by CTG expansion in the 3'-UTR of DMPK gene. This expansion results in the expression of toxic gain-of-function RNA that forms ribonuclear foci and disrupts normal activities of RNA-binding proteins belonging to the MBNL and CELF families. Changes in alternative splicing, translation, localization, and mRNA stability due to sequestration of MBNL proteins and up-regulation of CELF1 are key to DM1 pathology. However, recent discoveries indicate that pathogenic mechanisms of DM1 involves many other factors as well, including repeat associated translation, activation of PKC-dependent signaling pathway, aberrant polyadenylation, and microRNA deregulation. Expression of the toxic repeat RNA culminates in the developmental remodeling of the transcriptome, which produces fetal isoforms of proteins that are unable to fulfill the physiological requirements of adult tissues. This review will describe advances in the understanding of DM1 pathogenesis as well as current therapeutic developments for DM1.

KW - Alternative splicing

KW - Antisense oligonucleotides

KW - Developmental reprogramming

KW - Myotonic dystrophy

KW - RNA toxicity

UR - http://www.scopus.com/inward/record.url?scp=84924171954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924171954&partnerID=8YFLogxK

U2 - 10.1002/dvdy.24240

DO - 10.1002/dvdy.24240

M3 - Review article

C2 - 25504326

AN - SCOPUS:84924171954

VL - 244

SP - 377

EP - 390

JO - Developmental Dynamics

JF - Developmental Dynamics

SN - 1058-8388

IS - 3

ER -